Biocon’s contribution to breast cancer by CANMab drug

| January 28, 2014

article image
Breast cancer is a common, yet a life threatening condition, which originates from the mammary milk lobules. A vast majority of cases are encountered in women, with some scattered instances in men. Surgery, chemotherapy, hormonal therapy and/ or immunotherapy are the recommended treatment modalities, in order to avoid relapses and to increase survival rates. Globally, there are over 1.5 million cases reported every year.

Spotlight

Mölnlycke

A world-leading medical solutions company. We design and supply medical solutions to enhance performance in healthcare – from the hospital to the home. Around the world, healthcare systems and professionals are under pressure to deliver better care, to more people, for better value. They need innovative solutions they can trust. That’s where we come in. We’re here to advance performance in healthcare. So we’re always on the lookout for new ways to improve. Our focus: providing effective solutions and offering better value for money.

OTHER ARTICLES

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | March 16, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More
PHARMACY MARKET

A pharma outsourcing mission

Article | March 16, 2020

In a way, getting through the initial stages of a complex pharmaceutical project that is being outsourced to a contract development and manufacturing organization is like getting a rocket off the ground. Many drug developers express frustration with the time it often takes during the initial stages of working with a CDMO — from the time they first reach out to a CDMO for help until they receive a proposal. Some have described it as months of silence from when they send a request for proposal (RFP) until they have a proposal in hand. The initial stages of a relationship between drug sponsor and CDMO often do not get the attention it deserves, and valuable time is lost, delaying projects and delaying delivery of therapeutics to patients. The quick scheduling of the ACT meeting with the right attendees can deliver immediate answers to key questions needed by the drug sponsor for effective planning and can help propel projects to a successful launch.

Read More

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | March 16, 2020

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More

Spotlight

Mölnlycke

A world-leading medical solutions company. We design and supply medical solutions to enhance performance in healthcare – from the hospital to the home. Around the world, healthcare systems and professionals are under pressure to deliver better care, to more people, for better value. They need innovative solutions they can trust. That’s where we come in. We’re here to advance performance in healthcare. So we’re always on the lookout for new ways to improve. Our focus: providing effective solutions and offering better value for money.

Events